Stringency of #COVID19 lockdown correlates with negative economic growth in same period but with positive growth in future time period, observes #EconomicSurvey
A slew of structural reforms were announced, to enhance supply in the medium and long run, to strengthen primary and secondary sectors, create jobs and boost aggregate demand
#EconomicSurvey calls for counter-cyclical fiscal policy to be an important point of emphasis, where the govt. steps in when the private sector does badly and steps back when the private sector does well
The Sovereign Credit Rating Methodology needs correction, current ratings do not reflect fundamentals, they also affect foreign investment flow in a mechanical manner
Small levels of increase in public spending on healthcare can have a non-linear impact and result in a very large decrease in out-of-pocket expenditure by typical families on healthcare - CEA @SubramanianKri
Excessive regulation leads to excessive and opaque supervision and exercise of discretion, sounds CEA @SubramanianKri, making a call for simple regulation and transparent supervision
India has been an outlier in its global innovation performance, India must aspire to increase its Gross Expenditure on R&D from around 1.5% to 3% of GDP
🔶No. of vaccine doses administered- 25,07,556
🔷Active cases less than 1.75 lakhs
🔶Daily no. of deaths less than 125
🔷Cumulative positivity rate, 5.51% and declining: Secretary, @MoHFW_INDIA
Serum Institute of India, Pune submitted safety, immunogenicity, and efficacy data generated on 23,745 participants aged more than or equal to 18 years or older from overseas clinical studies. The overall vaccine efficacy was found to be 70.42%: DCGI
Bharat Biotech has developed a Whole Virion Inactivated Corona Virus Vaccine (Covaxin) in collaboration with @ICMRDELHI and NIV (Pune). This vaccine is developed on Vero cell platform, which has a well-established track record of safety & efficacy in the country & globally: DCGI
M/s Cadila Healthcare Ltd., has developed a Novel Corona Virus-2019-nCov-Vaccine using DNA platform technology. The interim data suggests that the vaccine is safe and immunogenic with three doses when administered intradermally: DCGI
#MissionKarmayogi will be a shift from Rules-based to Roles-based HR management linking training with development of competencies of civil servants with a big focus on e-learning